V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000353 | 230010772 | 1.57 | null | null | 2017-11-11 | 2020-03-03 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101630688 |
| 230000792 | 230010776 | null | null | null | 2021-06-21 | 2021-06-25 | Bevacizumab | 02 | null | BEVACIZUMAB | 101743297 |
| 230000869 | 230010777 | null | null | null | 2020-11-18 | 2020-12-02 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101278961 |
| 230001007 | 230010778 | 1.7 | 59 | Palliative (P) | 2022-02-18 | 2022-03-01 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100670947 |
| 230001176 | 230010779 | null | null | null | 2020-04-20 | 2020-04-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101863872 |
| 230001437 | 230010780 | 1.66 | 73.3 | Adjuvant (A) | 2021-10-30 | 2022-01-14 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | BEXAROTENE | 101374920 |
| 230001448 | 230010781 | 1.67 | 83.9 | null | null | 2020-05-22 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101207641 |
| 230002045 | 230010782 | 1.57 | 98.2 | Neo-adjuvant (N) | 2018-02-05 | 2018-02-19 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101121861 |
| 230002075 | 230010783 | 1.61 | 57.5 | null | null | 2020-01-23 | ICON9 TRIAL | 01 | null | ICON8B TRIAL | 101208932 |
| 230002146 | 230010784 | 1.66 | 106 | null | null | 2018-03-08 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100649868 |
| 230002313 | 230010785 | 1.72 | 63.7 | null | 2020-07-15 | 2020-07-30 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101541704 |
| 230002409 | 230010786 | 1.53 | 62.7 | null | null | 2019-10-28 | null | 02 | null | TRIAL UNSPECIFIED | 100843848 |
| 230001673 | 230010790 | null | null | null | 2019-01-03 | 2019-06-04 | null | 02 | null | TRIAL UNSPECIFIED | 101631811 |
| 230001096 | 230010935 | 1.56 | 96.6 | Neo-adjuvant (N) | null | 2020-05-20 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101649577 |
| 230001106 | 230010936 | null | null | null | null | 2021-03-18 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101600134 |
| 230001111 | 230010937 | null | null | null | null | 2022-04-14 | null | null | null | CARBOPLATIN + PACLITAXEL | 100358352 |
| 230001117 | 230010939 | 1.64 | 56.2 | Neo-adjuvant (N) | null | 2022-01-09 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100549390 |
| 230001118 | 230010940 | null | null | null | 2020-11-27 | 2020-12-15 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101648051 |
| 230001125 | 230010943 | null | 116 | null | null | 2019-04-23 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100389805 |
| 230001127 | 230010944 | 1.52 | 58.4 | null | null | 2019-11-25 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100683076 |
| 230001135 | 230010945 | null | null | null | 2021-05-31 | 2021-06-16 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100186203 |
| 230001136 | 230010946 | 1.64 | 58.5 | Adjuvant (A) | 2019-02-14 | 2019-02-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100427531 |
| 230001145 | 230010947 | null | null | null | null | 2020-10-10 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101777462 |
| 230001160 | 230010948 | null | null | null | null | 2022-02-06 | null | null | null | CARBOPLATIN + PACLITAXEL | 100743254 |
| 230001163 | 230010949 | null | null | null | 2021-03-22 | 2021-04-10 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101342813 |
| 230001169 | 230010950 | 1.68 | 81 | Palliative (P) | null | 2021-08-11 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100969785 |
| 230001173 | 230010951 | null | null | null | 2022-01-29 | 2022-02-02 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100000472 |
| 230001216 | 230010959 | null | null | null | null | 2021-03-21 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101143165 |
| 230001235 | 230010962 | 1.61 | null | null | null | 2021-08-23 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101312298 |
| 230001276 | 230010969 | 1.63 | 65 | null | 2019-11-02 | 2019-11-29 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100113407 |
| 230001285 | 230010970 | 1.63 | 63.3 | null | null | 2019-02-14 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101742436 |
| 230001298 | 230010971 | 1.72 | null | null | null | 2019-11-21 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100514502 |
| 230001307 | 230010974 | null | null | null | null | 2021-05-02 | null | null | null | CARBOPLATIN + PACLITAXEL | 100027980 |
| 230001336 | 230010978 | 1.64 | 61 | Adjuvant (A) | null | 2020-09-23 | CARBOPLATIN + PACLITAXEL | 2 | N | CARBOPLATIN + PACLITAXEL | 100167056 |
| 230001339 | 230010979 | null | null | null | 2020-12-05 | 2020-12-20 | null | null | null | CARBOPLATIN + GEMCITABINE | 101049833 |
| 230001341 | 230010980 | null | null | null | 2019-01-28 | 2019-08-16 | FLUOROURACIL + OXALIPLATIN | 02 | null | TRIAL UNSPECIFIED | 100129127 |
| 230001344 | 230010981 | null | null | null | 2021-01-08 | 2021-05-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100946609 |
| 230001351 | 230010983 | null | 50.6 | null | null | 2019-12-29 | null | null | null | NIVOLUMAB | 101745558 |
| 230001373 | 230010989 | null | null | null | 2021-10-01 | 2021-11-07 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100005114 |
| 230001381 | 230010990 | 1.59 | 65 | Palliative (P) | 2022-04-22 | 2022-04-23 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101298975 |
| 230001382 | 230010991 | null | null | null | null | 2021-04-15 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101834209 |
| 230001424 | 230010996 | 1.62 | 59.7 | null | 2021-01-29 | 2021-02-13 | Olaparib | 02 | null | OLAPARIB | 101077543 |
| 230001430 | 230010997 | 1.74 | 72 | null | 2022-04-08 | 2022-04-18 | Trial Unspecified | N | null | BEVACIZUMAB | 101396392 |
| 230001434 | 230010998 | null | null | null | null | 2020-06-28 | PACLITAXEL | 02 | null | PACLITAXEL | 100300880 |
| 230001443 | 230010999 | 1.6 | 50.9 | null | null | 2020-12-26 | CISPLATIN + GEMCITABINE | 99 | null | CARBOPLATIN | 100244625 |
| 230001452 | 230011001 | 1.5 | 102.95 | null | null | 2022-03-20 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100356661 |
| 230001474 | 230011004 | 1.67 | 99 | null | null | 2022-03-14 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100297309 |
| 230001499 | 230011006 | 1.55 | 48.5 | null | null | 2018-05-07 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100260155 |
| 230001504 | 230011009 | null | null | null | 2022-04-17 | 2022-04-25 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100267050 |
| 230001521 | 230011011 | 1.62 | 43.2 | Palliative (P) | 2017-05-25 | 2017-06-01 | null | 02 | N | TRIAL UNSPECIFIED | 101062463 |